antibiotic g 418 has been researched along with mefloquine in 1 studies
Studies (antibiotic g 418) | Trials (antibiotic g 418) | Recent Studies (post-2010) (antibiotic g 418) | Studies (mefloquine) | Trials (mefloquine) | Recent Studies (post-2010) (mefloquine) |
---|---|---|---|---|---|
515 | 0 | 102 | 2,212 | 342 | 560 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Baradaran-Heravi, A; Chow, CCT; Coltart, DM; Elmore, KE; Ferguson, MW; Gerak, CAN; Hosseini-Farahabadi, S; Rastelli, EJ; Roberge, M; Stahl, F | 1 |
1 other study(ies) available for antibiotic g 418 and mefloquine
Article | Year |
---|---|
The antimalarial drug mefloquine enhances TP53 premature termination codon readthrough by aminoglycoside G418.
Topics: Antimalarials; Codon, Nonsense; Codon, Terminator; Gentamicins; HCT116 Cells; Humans; Mefloquine; Peptide Chain Termination, Translational; Tumor Suppressor Protein p53 | 2019 |